PREVALENCE OF PSYCHOTROPIC MEDICATION TREATMENT IN ADULTS WITH INTELLECTUAL DISABILITIES IN GERMANY

被引：0
|
作者：
Dobrindt, J. [1 ]
Koch, A. [1 ]
Schuetzwohl, M. [1 ]
机构：
[1] Carl Gustav Carus Univ Hosp Dresden, Dept Psychiat & Psychotherapy, Psychiat Hlth Serv, Res Grp, Dresden, Germany
来源：
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH | 2019年 / 63卷 / 07期
关键词：
psychotropic medication; prevalence; PROMPT-ID study; Germany;
D O I：
暂无
中图分类号：
G76 [特殊教育];
学科分类号：
040109 ;
摘要：
引用
收藏
页码：696 / 696
页数：1
相关论文
共 50 条
  • [31] An investigation into the prevalence of psychopathology in adults with intellectual disabilities
    Biagini, Lucia
    Cooper, Sally-Ann
    [J]. SCOTTISH MEDICAL JOURNAL, 2014, 59 (01) : E35 - E35
  • [32] The prevalence and determinants of obesity in adults with intellectual disabilities
    Melville, C. A.
    Cooper, S. -A.
    Morrison, J.
    Allan, L.
    Smiley, E.
    Williamson, A.
    [J]. JOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES, 2008, 21 (05) : 425 - 437
  • [33] Medication use among adults with intellectual and developmental disabilities
    Cobigo, V.
    Ouellette-Kuntz, H.
    Lake, J. K.
    Wilton, A. S.
    Lunsky, Y.
    [J]. JOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES, 2014, 27 (04) : 320 - 320
  • [34] Assessing the impact of psychotropic medication changes on challenging behavior of individuals with intellectual disabilities
    Valdovinos, Maria G.
    Henninger-McMahon, Meara
    Schieber, Elizabeth
    Beard, Lisa
    Conley, Brenna
    Haas, Annette
    [J]. INTERNATIONAL JOURNAL OF DEVELOPMENTAL DISABILITIES, 2016, 62 (03) : 200 - 211
  • [35] Psychotropic Medication in Intellectual and Developmental Disabilities: Patterns of Use and Recommendations for Monitoring Effects
    Maria G. Valdovinos
    [J]. Current Developmental Disorders Reports, 2019, 6 : 195 - 201
  • [36] Psychotropic Medication in Intellectual and Developmental Disabilities: Patterns of Use and Recommendations for Monitoring Effects
    Valdovinos, Maria G.
    [J]. CURRENT DEVELOPMENTAL DISORDERS REPORTS, 2019, 6 (04) : 195 - 201
  • [37] Bedingungsfaktoren psychopharmakologischer Behandlung bei leichter oder mittelgradiger IntelligenzminderungDeterminants of psychotropic medication in adults with mild or moderate intellectual disabilities
    M. Schützwohl
    E. Voss
    M. Stiawa
    H.-J. Salize
    B. Puschner
    A. Koch
    [J]. Der Nervenarzt, 2017, 88 (11) : 1273 - 1280
  • [38] Prevalence of psychotropic medication use and association with challenging behaviour in adults with an intellectual disability. A total population study
    Bowring, D. L.
    Totsika, V.
    Hastings, R. P.
    Toogood, S.
    McMahon, M.
    [J]. JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2017, 61 (06) : 604 - 617
  • [39] Treatment of prolactin elevation by psychotropic drugs in people with intellectual disabilities
    Gonzalez-Pablos, E.
    Martin-Lorenzo, C.
    Valles-de la Calle, J. M.
    Paulino-Matos, P.
    [J]. MEDICINA DE FAMILIA-SEMERGEN, 2019, 45 (08): : E51 - E52
  • [40] Psychotropic medication in adults with mental retardation: prevalence, and prescription practices
    Holden, B
    Gitlesen, JP
    [J]. RESEARCH IN DEVELOPMENTAL DISABILITIES, 2004, 25 (06) : 509 - 521
12345